CLU Cellu Tissue Holdings USD0.01

Robbins Umeda LLP has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by members of the Board of Directors ("Board") of Cellu Tissue Holdings, Inc. ("Cellu Tissue" or the "Company") (NYSE: CLU) in connection with their efforts to sell Cellu Tissue to Clearwater Paper Corporation ("Clearwater Paper") (NYSE: CLW). If the transaction is completed, Cellu Tissue shareholders will receive $12.00 in cash for each share of Cellu Tissue common stock they hold. The transaction is expected to be completed in the fourth quarter of 2010.

Robbins Umeda LLP's investigation concerns whether the Cellu Tissue's Board undertook a fair process to obtain fair consideration for all shareholders of Cellu Tissue. Specifically, our investigation concerns whether the Company's Board breached their fiduciary duties to Cellu Tissue shareholders by failing to adequately shop the Company before entering into the transaction with Clearwater Paper. Of note, at least one analyst set a target price for the Company at $16.00 per share. Furthermore, the Company had an initial public offering on January 21, 2010, at which time the stock was offered at $13.00 per share, which is 8.33% higher than Clearwater's bid.

If you are a shareholder of Cellu Tissue, plan to continue to hold your shares, and would like more information about your rights as a shareholder, please contact attorney Gregory E. Del Gaizo at 800-350-6003 or by e-mail at info@robbinsumeda.com.

Robbins Umeda LLP is a California-based law firm with significant experience representing investors in merger-related shareholder class actions, shareholder derivative actions, and securities fraud class actions. For more information about the firm, please go to http://www.robbinsumeda.com.

Advertisement

Canada Life (NYSE:CLU)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025

Canada Life (NYSE:CLU)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025